GDP (gemcitabine, dexamethasone, cisplatin) salvage therapy results in superior progression free survival compared to mini-beam prior to autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma.

被引：1
|
作者：
Kuruvilla, J [1 ]
Nagy, T [1 ]
Pintilie, M [1 ]
Keating, A [1 ]
Crump, M [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Blood & Marrow Transplant Program, Toronto, ON, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.905.905
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
905
引用
收藏
页码：258A / 259A
页数：2
相关论文
共 50 条
  • [41] Peripheral blood stem cell mobilisation with cisplatin-containing regimens in patients with relapsed or refractory Hodgkin's lymphoma, candidates for an autologous stem cell transplantation
    Martí, E
    Sureda, A
    Arranz, R
    Córdoba, R
    Xicoy, B
    Caballero, M
    Sánchez, B
    Bello, J
    Roncero, MG
    Alvarez, I
    Pliego, A
    Abelián, PF
    García, M
    Ribera, J
    Rañada, JF
    Sierra, J
    BONE MARROW TRANSPLANTATION, 2006, 37 : S236 - S237
  • [42] Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation
    Fernandez de Larrea, C.
    Martinez, C.
    Gaya, A.
    Lopez-Guillermo, A.
    Rovira, M.
    Fernandez-Aviles, F.
    Lozano, M.
    Bosch, F.
    Esteve, J.
    Nomdedeu, B.
    Montserrat, E.
    Carreras, E.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1211 - 1216
  • [43] OUTCOMES OF ESHAP ( plus /-RITUXIMAB) AS SALVAGE CHEMOTHERAPY FOR RELAPSED OR REFRACTORY NON-HODGKIN'S LYMPHOMA FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION
    Alpoim, M.
    Badior, M.
    Pinto, R.
    Carneiro, A.
    Principe, F.
    Guimaraes, J. E.
    HAEMATOLOGICA, 2014, 99 : 719 - 719
  • [44] Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes
    Liu, Huimin
    Zou, Hesong
    Shan, Dandan
    Liu, Wei
    Huang, Wenyang
    Sui, Weiwei
    Deng, Shuhui
    Wang, Tingyu
    Lv, Rui
    Fu, Mingwei
    Xu, Yan
    Yi, Shuhua
    An, Gang
    Zhao, Yaozhong
    Qiu, Lugui
    Zou, Dehui
    CANCER MEDICINE, 2024, 13 (02):
  • [45] Day 15 natural killer (NK) cell recovery predicts progression free survival after autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Siddiqui, Mustaqeem A.
    Markovic, Svetomir N.
    Nevala, Wendy K.
    Uhl, Cindy B.
    Morice, William G.
    Porrata, Luis F.
    BLOOD, 2006, 108 (11) : 825A - 825A
  • [46] Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
    Younes, Anas
    Sureda, Anna
    Ben-Yehuda, Dina
    Zinzani, Pier Luigi
    Ong, Tee-Chuan
    Prince, H. Miles
    Harrison, Simon J.
    Kirschbaum, Mark
    Johnston, Patrick
    Gallagher, Jennifer
    Le Corre, Christophe
    Shen, Angela
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) : 2197 - 2203
  • [47] Progression-free survival at 24 months as a landmark after autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma.
    Tun, Aung M.
    Maliske, Seth
    Wang, Yucai
    Maurer, Matthew J.
    Micallef, Ivana N. M.
    Inwards, David James
    Porrata, Luis F.
    Rosenthal, Allison Claire
    Kharfan-Dabaja, Mohamed
    Orme, Jacob
    Link, Brian K.
    Cerhan, James Robert
    Thompson, Carrie A.
    Habermann, Thomas Matthew
    Witzig, Thomas E.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Bendamustine, Gemcitabine and Dexamethasone Chemotherapy Is Effective Salvage and Stem-Cell Mobilization Regimen in Patients with Relapsed or Refractory Hodgkin Lymphoma - Early Results of the Polish Lymphoma Research Group Study
    Paszkiewicz-Kozik, Ewa
    Zaucha, Jan
    Tyczynska, Agata
    Szymanski, Marcin
    Targonski, Lukasz
    Drozd-Sokolowska, Joanna
    Wojciechowska-Lampka, Elzbieta
    Tajer, Joanna
    Kurczab, Pawel
    Romejko-Jarosinska, Joanna
    Osowiecki, Michal
    Walewski, Jan
    BLOOD, 2017, 130
  • [49] Correlation of lymphocyte recovery and progression-free survival after autologous stem cell transplantation in patients with Hodgkin's lymphoma
    Mocikova, H.
    Vackova, B.
    Pytlik, R.
    Obrtlikova, P.
    Kobylka, P.
    Trneny, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S216 - S216
  • [50] Functional Imaging Predicts Progression-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Relapsed/Refractory Hodgkin Lymphoma
    Cho, Christina
    Eaton, Anne
    Barker, Juliet N.
    Castro-Malaspina, Hugo
    Devlin, Sean M.
    Moskowitz, Alison
    Sauter, Craig S.
    Moskowitz, Craig H.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S218 - S219
12345